niacinamide has been researched along with Peritonitis in 10 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In vivo treatment with ip administration of 3-aminobenzamide (10 mg/kg, 1 and 6 hrs after zymosan injection) or nicotinamide (50 mg/kg, 1 and 6 hrs after zymosan injection) significantly decreased mortality, inhibited the development of peritonitis, and reduced peroxynitrite formation." | 3.70 | Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. ( Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosinets, VA | 6 |
| Bagnenko, SF | 1 |
| Mirzabaev, AT | 1 |
| Batotsyrenov, BV | 1 |
| Gorbachev, NB | 1 |
| Miroshnichenko, VN | 1 |
| Batotsyrenova, KhV | 1 |
| Velikiĭ, KF | 1 |
| Gostishchev, VK | 1 |
| Matusevich, EA | 2 |
| Adamenko, GP | 1 |
| Osochuk, SS | 1 |
| Iarotskaia, NN | 2 |
| Cuzzocrea, S | 1 |
| Zingarelli, B | 1 |
| Costantino, G | 1 |
| Sottile, A | 1 |
| Teti, D | 1 |
| Caputi, AP | 1 |
| Nadtoka, VL | 1 |
1 trial available for niacinamide and Peritonitis
| Article | Year |
|---|---|
[Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
Topics: Adult; Antioxidants; Drug Combinations; Endotoxemia; Female; Flavin Mononucleotide; Free Radicals; H | 2011 |
9 other studies available for niacinamide and Peritonitis
| Article | Year |
|---|---|
[Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
Topics: Animals; Antioxidants; Drug Combinations; Flavin Mononucleotide; Free Radicals; Inosine Diphosphate; | 2010 |
[Metabolic immunocorrection treatment of experimental widespread purulent peritonitis].
Topics: Animals; Cardiotonic Agents; Cell Movement; Disease Models, Animal; Drug Combinations; Escherichia c | 2012 |
[Correction of protein-lipid composition in liver mitochondria during experimental widespread purulent peritonitis].
Topics: Animals; Cholesterol; Drug Combinations; Flavin Mononucleotide; Inosine Diphosphate; Male; Mitochond | 2012 |
[The immune activity of cytoflavine in the treatment of the diffuse septic peritonitis].
Topics: Adult; Cell Movement; Combined Modality Therapy; Drug Combinations; Female; Flavin Mononucleotide; H | 2012 |
[Metabolic correction of the lipid-transport system in experimental diffuse purulent peritonitis].
Topics: Animals; Biological Transport; Combined Modality Therapy; Drug Combinations; Drug Monitoring; Flavin | 2012 |
[Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis].
Topics: Animals; Bacillus; Drug Combinations; Escherichia coli; Flavin Mononucleotide; Injections, Intraperi | 2012 |
[Free-radical oxidation in liver during experimental widespread purulent peritonitis].
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Drug Combinations; Flavin Mononuc | 2012 |
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multip | 1999 |
[The Soviet antibacterial drug chlorophillipt].
Topics: Animals; Anti-Bacterial Agents; Bronchitis; Burns; Carrier State; Depression, Chemical; Drug Resista | 1970 |